Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Pneumol Clin ; 69(6): 315-9, 2013 Dec.
Article in French | MEDLINE | ID: mdl-24183291

ABSTRACT

This is a retrospective study conducted from January 2008 to December 2010 on sectional descriptive analysis of records of patients treated for MDR-TB and whose follow-up was in the thoracic department of Centre Hospitalier Universitaire (CHU) of Cocody in Abidjan Côte d'Ivoire. We selected eight patients who met the inclusion criteria of 21 MDR-TB patients registered during the study period. The average age was 29.25years ranging from 21 to 39. Males accounted for 75% of the patients (6 males and 2 females). The students represented the professional social layer most affected with 37.5% of the patients. All patients had a history of tuberculosis and only one patient was HIV positive under anti-retroviral (zidovudin, lamivudin and efavirenz). All cultures found Mycobacterium tuberculosis. The resistance profile in addition to isoniazid and rifampicin, found two cases of resistance to ethambutol and streptomycin. The chest radiograph at the time of initiation of second-line treatment showed essentially excavations in 75% of cases and infiltrates in 25%. The lesions were bilateral in 7 of 8 patients (87.5%). The main side effects observed during treatment were limited to cochleovestibular disorders (2 patients) and neuropsychiatric disorders (2 patients) and digestive disorders in half of the patients with removal of the offending molecule kanamycin. After 24months of treatment, it was numbered five cures (62.5%), two failures and one death.


Subject(s)
Tuberculosis, Multidrug-Resistant/therapy , Adult , Antitubercular Agents/therapeutic use , Cote d'Ivoire/epidemiology , Drug-Related Side Effects and Adverse Reactions/epidemiology , Ethambutol/therapeutic use , Female , Hospitals, University/statistics & numerical data , Humans , Isoniazid/therapeutic use , Male , Medication Adherence/statistics & numerical data , Retrospective Studies , Rifampin/therapeutic use , Tuberculosis, Multidrug-Resistant/epidemiology , Withholding Treatment/statistics & numerical data , Young Adult
2.
Rev Epidemiol Sante Publique ; 60(6): 484-8, 2012 Dec.
Article in French | MEDLINE | ID: mdl-23068424

ABSTRACT

BACKGROUND: Very few works approach elderly's tuberculosis (TB) in developing countries. The aim of this study is to present elderly's TB epidemiology and the outcomes of the ambulatory follow-up of the tuberculous patients aged more than 65years old (TBE) compared to the TB among patients less than 65years old (TBY). METHODS: Our study is retrospective covering period of January 1999 to June 2006 activities of Adjamé's antituberculous center. It is a comparative study between patients of at least 65 years and patients of less than 65years when the diagnosis of TB was made. RESULTS: Among 36,923 cases of TB, the proportion of TBE is 2.33%. In case of TBE, the sex-ratio is 2.16 versus 1.50 among TBY (P<0.001). Localization of TB is pulmonary in 61.70% among TBE versus 67.26% among TBY (P=0.058). Among elderly's TB, the osteoarticular localization is more frequent. TB-VIH co-infection prevalence is estimated to 9.05% among elderly's TB versus 44.38% among patients of less than 65 years (P<0.001). The therapeutic success rate within elderly patients is 52.16% years versus 61.42% when it was patients of less than 65 years. The proportion of lost at follow-up and the rate of patient transfers within the elderly's TB are the most raised. CONCLUSION: The elderly's TB is rare with a more masculine predominance. TB-VIH co-infection is not important among elderly's TB. The aged patient follow-up must be improved.


Subject(s)
Developing Countries/statistics & numerical data , Mycobacterium tuberculosis , Tuberculosis/epidemiology , Aged , Aged, 80 and over , Ambulatory Care , Cote d'Ivoire/epidemiology , Female , Humans , Male , Prevalence , Retrospective Studies
3.
Rev Pneumol Clin ; 67(3): 170-3, 2011 Jun.
Article in French | MEDLINE | ID: mdl-21665082

ABSTRACT

Multidrug resistance is defined as a resistance to two major antituberculosis drugs, which are isoniazid and rifampicin. The aim of the study was to specify the place of the thoracic surgery during the medical follow-up of the TB-MDR. Five files were kept over six years during this retrospective study. On the clinical and radiological level, localised lesions and a negative HIV serology were noted in the five patients. The completion date of the surgery varied between the third month and the 22nd after the beginning of the medical treatment. This delay in carrying out the surgery was encouraged by the social conditions of the patients. Three series of expectoration culture post-surgery were all negative. After surgery, the medical treatment was drawn out over six and 12 months depending on the clinical condition of the patient. No recurrence was observed. Only one patient died one year after the surgery from hemoptysis in relation to pulmonary sequelae.


Subject(s)
Pneumonectomy , Tuberculosis, Multidrug-Resistant/surgery , Adult , Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Isoniazid/pharmacology , Isoniazid/therapeutic use , Male , Middle Aged , Mycobacterium tuberculosis/drug effects , Pneumonectomy/methods , Pulmonary Medicine , Retrospective Studies , Rifampin/pharmacology , Rifampin/therapeutic use , Treatment Outcome , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/mortality
4.
Rev Pneumol Clin ; 67(2): 82-8, 2011 Apr.
Article in French | MEDLINE | ID: mdl-21497721

ABSTRACT

BACKGROUND: The Ivory Coast management of chronic tuberculosis (TB) began in 2000. OBJECTIVES: The aim of this study is to determine the characteristics of the patients monitored for chronic TB and note the difficulties in patient management and outcome. METHOD: A retrospective review of the medical records of the patients receiving second-line treatment for chronic tuberculosis for at least 12 months. RESULTS: Eighty-one medical records were included. The average of age was 33.37 years. The sex ratio was 2.68. All of the patients lived in conditions of promiscuity. The recommendations for the treatment of failures and relapses were not always respected: 33.33% did not comply with the protocols, 53.1% non-prescription of the mycobiogramme and 22.2% non-respect for the follow-up calendar. During the diagnosis of the chronic tuberculosis, bilateral radiological lesions were found in 72.5% of the cases and one lung was destroyed in 14.7% of the cases. The isolates were Mycobacterium tuberculosis. The multi-drug-resistance of Mycobacterium tuberculosis was estimated at 95.5%. The side effects of the treatments were polymorphous with a frequency ranging from 46.4% to 61.3% during the follow-up period. The outcome of the patients is the following: 39.2% dropped out; 15.2% died; 30.4% were in the attack phase; 5.1% were cured; 5.1% were in the consolidation phase. CONCLUSION: The results of the treatment are disappointing. It is urgent to develop a strategy to reduce the number of drop-outs and provide the early diagnosis and treatment of multi-drug resistant tuberculosis.


Subject(s)
Antitubercular Agents/therapeutic use , Developing Countries , Tuberculosis, Multidrug-Resistant/drug therapy , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/transmission , Adolescent , Adult , Aged , Antitubercular Agents/adverse effects , Cote d'Ivoire , Cross-Sectional Studies , Drug Therapy, Combination , Female , HIV Infections/diagnosis , HIV Infections/drug therapy , HIV Infections/transmission , Humans , Male , Medication Adherence , Middle Aged , Patient Dropouts , Retrospective Studies , Social Environment , Socioeconomic Factors , Survival Rate , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/mortality , Tuberculosis, Multidrug-Resistant/transmission , Young Adult
5.
Med Trop (Mars) ; 65(6): 602-3, 2005 Nov.
Article in French | MEDLINE | ID: mdl-16555523

ABSTRACT

Three cases of visceral leishmaniasis were observed in a cohort of 528 patients admitted to the Department of Pulmonary Disease of the Cocody University Hospital Center in Abidjan, Côte d'Ivoire from June 2001 to May 2002. All three patients including 2 women and 1 man were young Ivorians. Assessment of predisposing factors demonstrated that all three patients had diminished immune systems resulting from long-term (2-month) steroid therapy in one patient and AIDS with low rates of CD4 T cells around 100 cells/microl in 2 patients. Clinical features were variable but mainly involved constant refractory fever, anaemia, lymphadenopathy and pleurisy with clear fluid. Despite treatment with meglumine antimoniate, two patients died within the first weeks.


Subject(s)
Leishmaniasis, Visceral , Adult , Cote d'Ivoire , Fatal Outcome , Female , Humans , Leishmaniasis, Visceral/diagnosis , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...